Pretomanid

CAS 187235-37-6 2 current recordsSmall Molecule

Who holds supplier records for Pretomanid? 2 organisations hold a current record for Pretomanid: an active US FDA Type II Drug Master File.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pretomanid: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pretomanid

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pretomanid. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • SHENYANG HONGQI PHARMACEUTICAL CO LTD
    Active DMF 38642 · latest filing Sept 2023
  • TIANISH LABORATORIES PRIVATE LTD
    Active DMF 38796 · latest filing Oct 2023
Need Pretomanid sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Pretomanid). The latest listed exclusivity runs to 14 Aug 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Pretomanid is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL227875).

Chemical identity

IUPAC name
(6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
Canonical SMILES
C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F
InChIKey
ZLHZLMOSPGACSZ-NSHDSACASA-N
Synonyms
Dovprela (previously pretomanid fgk), PA 824, PA-824, PA824, Pretomanid, PA824 cpd, pretomanidum, RefChem:57158, (S)-PA 824, MMV688755, (S)-PA 824 (Pretomanid), Pretomanid [USAN:INN]

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antimycobacterial
Mechanism of action
Organic Anion Transporter 3 Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pretomanid?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Pretomanid: SHENYANG HONGQI PHARMACEUTICAL CO LTD and TIANISH LABORATORIES PRIVATE LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pretomanid Drug Master Files are active?

SHENYANG HONGQI PHARMACEUTICAL CO LTD (DMF 38642) and TIANISH LABORATORIES PRIVATE LTD (DMF 38796). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Pretomanid supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pretomanid?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.